Francisco Partners has completed the acquisition of McKesson Automation, a unit of McKesson Corporation that offers pharmacy automation services to hospitals and health systems. The company was renamed Aesynt upon closing.
Aesynt offers pharmacy automation services to hospitals and health systems. The company offers a range of products addressing every stage of medication delivery within a hospital, including pharmacy, nursing and surgical services. The company is based in Pittsburgh (www.aesynt.com).
“We are increasingly excited about Aesynt’s potential. The company is known for its deep knowledge of the medication delivery process, and we support Aesynt’s leadership team and its strategy to develop compelling automation solutions for medication management,” said Chris Adams, a principal at Francisco Partners.
Francisco Partners makes investments in technology companies with transaction values ranging from $50 million to $2 billion. Transaction structures include buyouts, divisional divestitures, recapitalizations, restructurings and growth equity financings. Francisco Partners is headquartered in San Francisco (www.franciscopartners.com).
“McKesson Automation is highly regarded in the healthcare industry for its system-wide approach to and deep understanding of the medication delivery process,” said Mr. Adams. “We are excited to work closely with the existing leadership team to expand the automation business as a standalone company. We will maintain a close working relationship with McKesson Corporation to ensure that the companies’ collective solutions for hospitals and healthcare providers are complementary and effective.”
© 2013 PEPD • Private Equity’s Leading News Magazine • 11-4-13